How Carcinogens Got Into the Generic U.S. Drug Supply

The video discusses the contamination of widely used blood pressure drugs with a carcinogen due to a manufacturing change by a Chinese supplier. The FDA's limited testing and reliance on manufacturers for safety assurance are highlighted. The contamination spread as other manufacturers adopted the faulty process, leading to recalls. Some pharmacies, like one in New Haven, CT, have taken independent steps to test drugs, rejecting a significant percentage. The FDA is investigating the issue's broader implications.

What was the response of the pharmacy in New Haven, CT regarding drug testing?

What challenges do consumers face regarding drug safety as mentioned in the text?